STAT3/NF‐κB signalling disruption in M2 tumour‐associated macrophages is a major target of PLGA nanocarriers/PD‐L1 antibody immunomodulatory therapy in breast cancer
Cavalcante, Rômulo S. ; Ishikawa, Uta ; Silva, Emanuell S. ; Silva‐Júnior, Arnóbio A. ; Araújo, Aurigena A. ; Cruz, Luis J. ; Chan, Alan B. ; Araújo Júnior, Raimundo F.
British journal of pharmacology, 2021-06, Vol.178 (11), p.2284-2304 [Periódico revisado por pares]England: Blackwell Publishing Ltd
Texto completo disponível